Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Overview of attention for article published in Journal of the National Comprehensive Cancer Network (JNCCN), May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 2 X users

wikipedia: 2 Wikipedia pages
guideline: 2 clinical guideline sources

Readers on

mendeley: 155 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Sonidegib (Odomzo) for Basal Cell Carcinoma - Details - Sonidegib (Odomzo) BCC – Final Clinical Guidance Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 19 Jun 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.